Target intelligence / Profile preview

Neutral Sphingomyelinase 2 (nSMase2)

Target
nSMase2
Molecular classification
Enzyme, Hydrolase
01

Overview

Neutral sphingomyelinase 2 (nSMase2) is a membrane-bound enzyme that catalyzes the hydrolysis of sphingomyelin to generate ceramide and phosphocholine. Ceramide, a bioactive lipid, is involved in various cellular processes including inflammatory signaling, exosome generation, cell growth regulation, and apoptosis. nSMase2 is implicated in diseases such as cancer, neurodegeneration, and inflammatory disorders, making it a potential therapeutic target.

Other names
SMPD3
02

Mechanism of action

Lipid competitive inhibitor (e.g., GW4869)

03

Biological functions

Ceramide productionInflammatory signalingExosome generationCell growth regulationApoptosis inductionImmune responseBone mineralizationHIV maturation
04

Disease associations

CancerNeurodegenerative diseaseInflammationVascular dysfunctionHIV/AIDS
05

Interacting drugs

GW4869

Beyond the preview

Go deeper on Neutral Sphingomyelinase 2 (nSMase2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutral Sphingomyelinase 2 (nSMase2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call